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Abstract: Three new caryophyllene sesquiterpenoids, cytosporinols A–C (1–3), have been isolated from solid cultures of  
Cytospora sp. The structures of 1–3 were elucidated primarily by NMR spectroscopy, and 3 was further confirmed by X-ray  
crystallography. The absolute configurations of the C-11 secondary alcohol in 1 and the 6,8-diol moiety in 3 were deduced using 
the modified Mosher and Snatzke’s method, respectively. Compounds 2 and 3 showed moderate cytotoxicity against HeLa cells. 
Keywords: caryophyllene sesquiterpenoid, cytosporinol, Cytospora sp.
Introduction 
Caryophyllene sesquiterpenoids have been isolated 
frequently from fungi as the bioactive principles. Examples 
include the pestalotiopsins, immunosuppressive and cytotoxic 
agents produced by the endophyte Pestalotiopsis sp. isolated 
from Taxus brevifolia;1,2 pestalotiopsolide A, teadolidol, and 
6-epiteadolidol, highly oxidized caryophyllenes from a 
Pestalotiopsis sp. endophytic to the bark of Pinus taeda;3 the 
6-hydroxpunctaporonins, antibacterial metabolites from a 
fungicolous Pestalotiopsis disseminata;4 fuscoatrol A, a 
cytotoxic agent from a marine-derived Humicola fuscoatra 
KMM 4629;5 the punctaporonins (also named as punctatins), 
antifungal agents from a coprophilous Poronia punctata;6–11 
walleminol and walleminone, two cis-fused iso-caryophyllenes 
from the toxigenic fungus Wallemia sebi;12 and Sch 725432, 
601253, 601254, and 725434, antifungal agents from 
Chrysosporium pilosum.13 
During an ongoing search for new bioactive natural  
products from fungi of unique habitats, we initiated chemical 
studies of the fungi either inhabiting the fruiting body and 
larvae of Cordyceps sinensis14 or its surface soil.15 As an  
extension, we also studied those species isolated from the soil 
samples that were collected on the Qinghai-Tibetan plateau at 
altitudes above 3,200 m, the environment in which Cordyceps 
sinensis was typically found. Our initial investigation of such 
an ascomycetous fungus Cytospora sp. led to the isolation of 
three antimicrobial caryophyllene-derived meroterpenoids.16 
Since the HPLC chromatogram of the crude extract revealed 
the presence of some minor components that could be the  
cytotoxic principles remained to be identified, the fungus was 
refermented in a larger scale using the same solid fermentation 
culture medium in which the meroterpenoids were first isolat-
ed.16 Fractionation of an EtOAc extract afforded three new 
caryophyllene sesquiterpenoids which we named cytosporinols 
A–C (1–3). Details of the isolation, structure elucidation, and 
cytotoxicity of these compounds are described herein. 
 
Results and Discussion 
Cytosporinol A (1) was assigned the molecular formula 
C16H24O4 (five degrees of unsaturation) by HRESIMS.  
Analysis of its NMR data (Table 1) revealed two exchangeable 
protons (δH 3.37 and 3.93, respectively), four methyl groups 
(one O-methyl), two methylenes, six methines including four 
oxymethines, two sp3 quaternary carbons (one oxygenated), 
and one tetrasubstituted olefin. These data accounted for all 
the 1H and 13C NMR resonances, suggesting that 1 was a  
tetracyclic compound. The 1H–1H COSY NMR data showed 
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two isolated spin-systems of C-10–C-1–C-3 (including OH-11 
and C-12) and C-6–C-7 (including OH-6). Interpretation of the 
HMBC data of 1 established a cyclobutane partial structure 
with two methyl groups attached to C-4. HMBC cross-peaks 
from H-6 to C-2 and from H2-7 to C-5 indicated that C-6 is 
attached to the cyclobutane ring at C-5. The H2-7 protons were 
correlated to C-8, C-9, and C-15, while the Me-15 protons 
were correlated to C-7, C-8, and C-9 in the HMBC spectrum 
of 1, linking the C-8 olefinic carbon (δC 130.2) to C-7, C-9 (δC 
134.5), and C-15. HMBC correlations from H-10 to C-8 and 
C-12, H-11 to C-9, and from H-12 to C-8 connected C-9 to 
both C-10 and C-12, completing the partial structure with a 
cyclopentane moiety fused to a cyclooctene unit at C-1/C-9. 
The key HMBC correlation from H-12 to C-5 (δC 95.5)  
connected both C-5 and C-12 (δC 89.6) to the same oxygen 
atom to form a tetrahydrofuran (THF) ring fused to the  
cyclobutane and cyclopentane moieties at C-2/C-5 and  
C-1/C12, respectively. The HMBC correlation from the O-
methyl proton signal Me-16 (δH 3.12) to the C-10 oxymethine 
carbon (δC 86.4) located the only methoxy group at C-10. On 
the basis of these data, the planar structure of 1 was  
established. 
The relative configuration of 1 was deduced by analysis of 
the 1H–1H coupling constants and NOESY data (Figure 1). 
The vicinal coupling constants observed for H-1 with H-11 
and H-12 were 7.4 and 6.5 Hz, respectively, suggesting their 
cis-relative orientation,17 consistent with a similar THF moiety 
found in the known compound punctaporonin C (4).9,18 
NOESY correlations of Me-13 with H-2, H-3a, and H-6  
indicated that these protons are all on the same face of the ring 
system, whereas those of H-3b with H-1 and Me-14, and of  
H-12 with Me-16 were used to place them on the opposite face. 
Collectively, these data allowed assignment of the relative 
configuration of 1. The 1S, 2R, 5S, 6S, 10R, 11R, and 12S  
absolute configurations were deduced for the stereogenic  
centers in 1 using the modified Mosher method19 as illustrated 
in Figure 2, which were also consistent with those assigned for 
corresponding stereogenic centers in 4.18 
Cytosporinol B (2) was assigned the same molecular  
formula C16H24O4 as 1 by HRESIMS. Analysis of its NMR 
data (Table 2) revealed structural fragments similar to those 
presented in 1. However, the C-8–C-15 unit and the C-9  
olefinic carbon (δC 134.5) were replaced by a terminal olefin 
(δH/δC 4.87/117.3, 144.7) and a methine (δH/δC 2.90/58.0), 
respectively, which were supported by relevant 1H–1H COSY 
and HMBC correlations. Therefore, the planar structure of 2 
was proposed as shown. The relative configuration of 2 was 
also determined by analysis of the 1H–1H coupling constants 
and NOESY data (Figure 1). The coupling patterns and 
NOESY correlations for the relevant protons in 2 were nearly 
identical to those of 1, indicating that they possess the same 
relative configuration, except for the additional stereogenic 
center C-9, which was assigned by comparison of the coupling 
constant between H-9 and H-12 (9.7 Hz) with that reported for 
4.9,18 This assignment was supported by NOESY correlations 
of H-9 with H-1 and Me-16. Considering the absolute  
configuration established for 1 by the modified Mosher  
method, C-9 was deduced to have the S configuration. 
Cytosporinol C (3) gave a pseudomolecular ion [M + Na]+ 
peak by HRESIMS, consistent with a molecular formula of 
C20H34O5 (four degrees of unsaturation). Analysis of its NMR 
data (Table 2) indicated that it is closely related to 1 and 2, 
except that the C-8/C-9 olefin in 1 or the C-8/C-15 terminal 
olefin in 2 was hydrated, and the OH-11 exchangeable proton 
(δH 3.93 in 1; 4.28 in 2) was replaced by a n-butyl group.  
These observations were supported by HMBC correlations 
from Me-15 to C-7, C-8, and C-9, and from the oxymethine 
proton H-11 to C-17, respectively. The relative configuration 
of 3 was assigned on the basis of NOESY data, and was  





1a R = (R)-MTPA ester












Figure 2.  ∆δ values (in ppm) = δS – δR obtained for (R)- and 
(S)-MTPA esters 1a and 1b 
Table 1. NMR data (400 MHz, acetone-d6) for 1 
pos. δH (J in Hz) δC, type HMBCa 
1 2.44, ddd (7.4, 6.5, 2.9) 56.1, CH 3, 9, 10 
2 2.98, td (8.1, 2.9) 39.9, CH  
3a 1.83, dd (11.1, 8.1) 43.5, CH2 1, 2, 4, 5, 14 
3b 1.36, dd (11.1, 8.1)  1, 2, 14 
4  38.7, qC  
5  95.5, qC  
6 4.04, ddd (12.0, 7.4, 4.8) 77.5, CH 2 
7a 3.22, t (12.0) 39.7, CH2 5, 6, 8, 9, 15 
7b 1.85, dd (12.0, 7.4)  5, 6, 8, 9, 15 
8  130.2, qC  
9  134.5, qC  
10 3.82, s 86.4, CH 1, 8, 11, 12, 16 
11 4.02, dd (7.4, 4.3) 73.8, CH 2, 9, 10
12 5.10, d (6.5) 89.6, CH 2, 5, 8 
13 1.36, s 27.9, CH3 3, 4, 5, 14 
14 1.02, s 24.1, CH3 3, 4, 5, 13 
15 1.74, s 22.1, CH3 7, 8, 9 
16 3.12, s 55.0, CH3 10 
OH-6 3.37, d (4.8)  5, 6 
OH-11 3.93, d (4.3)   
aHMBC correlations, optimized for 8 Hz, are stated from proton(s) 
to the indicated carbons. 
 
Figure 1.  Key NOESY correlations for cytosporinols A (1) 
and B (2) 
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(Figure 3). 
The absolute configuration of the cis-6,8-diol moiety in 3 
was assigned using the in situ dimolybdenum CD method  
developed by Frelek.20,21 Upon addition of dimolybdenum 
tetraacteate [Mo2(OAc)4] to a solution of 3 in DMSO, a metal 
complex was generated as an auxiliary chromophore. Due to 
the absence of other chromophores in 3, the observed sign of 
the Cotton effect in the induced spectrum originates solely 
from the chirality of the 6,8-diol moiety expressed by the sign 
of the “parallel” mode for Mo-O-C-C-C-O-Mo.22 When the 
molecule is viewed along the O-C bonds (Figure 4), the upper 
left and lower right sectors are defined as negative, whereas 
the upper right and lower left ones are defined as positive. The 
predicted sign of the Cotton effect depends upon the sign of 
the sector occupied by the largest part of the molecule. The 
negetive Cotton effect observed at around 400 nm (band II) in 
the induced CD spectrum of 3 (Figure 5) permitted assignment 
of the 6S and 8R absolute configuration on the basis of the 
empirical rule proposed by Snatzke.20 Therefore, 3 was  
assigned 1R, 2R, 5S, 6S, 8R, 9S, 10R, 11R, and 12S absolute 
configuration. 
Compounds 2 and 3 showed modest cytotoxicity against 
HeLa (cervical epithelium) cells, showing IC50 values of 16.5 
and 21.1 µM, respectively, while the positive control cisplatin 
showed an IC50 value of 7.6 µM. However, compound 1 did 
not show noticeable cytotoxic effects against HeLa cells 
(IC50 > 100 µM). 
Cytosporinols A–C (1–3) are closely related to the known 
taedolidol,3 6-epitaedolidol,3 and punctaporonin C (4),7–9 all 
possessing the rare oxatetracyclo[6.3.2.01,4.05,13]tridecane  
skeleton, but differ by having different substituents at C-6 (1), 
C-10 (1–3), and C-11 (3), as well as a tetrasubstituted olefin (1) 
and a terminal olefin (2). In addition, 1–3 are structurally  
similar to a synthetic byproduct 5 created in the acid-mediated 
Table 2. NMR data for 2 (acetone-d6) and 3 (CDCl3) 
 
pos. 
cytosporinol B (2)  cytosporinol C (3) 
δHa (J in Hz) δCb, type HMBCc  δHa (J in Hz) δCb, type HMBCc NOESYd
1 2.74, ddd (7.0, 5.8, 3.0) 60.1, CH 3, 9, 10  2.89, td (7.5, 3.3) 56.8, CH 3, 9, 10 3b 
2 2.78, ddd (9.4, 6.2, 3.0) 34.8, CH 3  2.46, td (9.8, 3.3) 33.5, CH 4, 6, 11 10 
3a 1.87, dd (11.6, 9.4) 41.2, CH2 1, 2, 4, 5, 13  1.95, dd (11.3, 9.8) 40.2, CH2 1, 2, 4, 5, 13, 14  
3b 1.32, dd (11.6, 6.2) 1, 2, 4, 5, 13, 14 1.36, dd (11.3, 9.8) 1, 2, 4, 5, 13, 14 1, 14
4  37.5, qC    37.3, qC   
5  96.0, qC    95.4, qC   
6 3.93,d t (11.9, 3.2) 68.4, CH   4.16, br  71.4, CH 8 15 
7a 2.65, dd (14.0, 3.2) 38.6, CH2 8, 15  2.05, dd (16.0, 3.5) 40.3, CH2 9 10 
7b 2.19, dd (14.0, 3.2)  15  1.85, dd (16.0, 3.5)  5, 6, 8, 9, 15  
8  144.7, qC    76.0, qC   
9 2.90, dd (9.7, 5.0) 58.0, CH 8, 10, 12  2.25, t (7.5) 56.9, CH 1, 7, 8, 10, 12, 15  
10 3.58, t (5.0) 92.1, CH 8, 11, 12, 16  3.26, t (7.5) 87.7, CH 8, 9, 11, 16 2, 7a, 15, 17 
11 4.04, ddd (5.8, 5.0, 4.3) 76.3, CH 2, 10  3.72, t (7.5) 84.4, CH 2, 10, 17 16 
12 4.81, dd (9.7, 7.0) 84.8, CH 2, 5  4.98, t (7.5) 83.9, CH 2, 5, 8  
13 1.17, s 26.7, CH3 3, 4, 5, 14 1.21, s 26.4, CH3 3, 4, 5, 14 
14 0.97, s 24.6, CH3 3, 4, 5, 13  1.08, s 24.5, CH3 3, 4, 5, 13 3b 
15a 4.87, d (4.9) 117.3, CH2 7, 9  1.19, s 30.0, CH3 7, 8, 9 6, 10 
15b 4.81, d (4.9)  7, 9      
16 3.27, s 57.5, CH3 10  3.35, s 57.5, CH3 10 11 
17     3.34, t (6.3) 69.4, CH2 11, 18, 19 10 
18     1.52, m 32.0, CH2 17, 19, 20  
19     1.35, m 19.4, CH2 17, 18, 20  
20     0.90, t (7.4) 13.8, CH3 18, 19  
OH-6 2.32, d (11.9)    3.37, d (4.8)  5, 6  
OH-11 4.28, d (4.3)   
aRecorded at 500 MHz; bRecorded at 100 MHz; cHMBC correlations, optimized for 8 Hz, are stated from proton(s) to the indicated  
carbons; dRecorded at 400 MHz. 
 
Figure 3.  Thermal ellipsoid representation of 3  
Figure 4.  Projection of the sector rule for the 6,8-diol moiety 
in 3 
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cyclization of the nonatural enantiomer pestalotiopins,23,24 but 
differ in having different configurations for all stereogenic 
centers and substituents at C-6 and C-11, respectively.  
Biogenetically, 1–3 could be derived from co-isolated  
fuscoatrol A5 as proposed for the cytosporolides,16 first via 
addition and cyclization to form 6, an intermediate of the C-6 
deacetylate of (+)-pestalotiopsin A,1 and then the acid-
catalyzed cyclizations of 6 via two intermediates 7 and 8 could 
afford the key putative intermediate 9,23 from which 1–3,  
taedolidol,3 6-epitaedolidol,3 and punctaporonin C (4)7–9 could 
be generated via different routes (Scheme 1). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Perkin-Elmer 241 polarimeter, and UV data 
were recorded on a Shimadzu Biospec-1601 spectrophoto-
meter. CD spectra were recorded on a JASCO J-815 
spectropolarimeter. IR data were recorded using a Nicolet 
Magna-IR 750 spectrophotometer. 1H and 13C NMR data were 
acquired with Varian Mercury-400 and -500 spectrometers 
using solvent signals (acetone-d6: δH 2.05/δC 29.8, 206.1; 
pyridine-d5: δH 7.21, 7.58, 8.73; CDCl3: δH 7.26/δC 76.7) as 
references. The HMQC and HMBC experiments were 
optimized for 145.0 and 8.0 Hz, respectively. ESIMS data 
were recorded on a Bruker Esquire 3000plus spectrometer, and 
HRESIMS data were obtained using Bruker APEX III 7.0 T 
and APEX II FT-ICR spectrometers, respectively. 
 
Fungal Material. The culture of Cytospora sp. was isolated 
by Yang Hao from a soil sample collected on the Qinghai-
Tibetan plateau at an altitude above 3,200 m, Linzhi, Tibet, 
China, in April, 2007. The isolation and identification of the 
strain have been previously described.16a The fungus was 
cultured on slants of PDA at 25 °C for 10 days. Agar plugs 
were cut into small pieces (about 0.5 × 0.5 × 0.5 cm3) under 
aseptic conditions, 15 pieces were used to inoculate in three 
Erlenmeyer flasks (250 mL), each containing 50 mL of media 
(0.4% glucose, 1% malt extract, and 0.4% yeast extract); the 
final pH of the media was adjusted to 6.5 and sterilized by 
autoclave. Three flasks of the inoculated media were incubated 
at 25 °C on a rotary shaker at 170 rpm for five days to prepare 
the seed culture. Spore inoculum was prepared by suspending 
the seed culture in sterile, distilled H2O to give a final 
spore/cell suspension of 1 × 106/mL determined by microscope 
and hemocytometer. Fermentation was carried out in 12 
Fernbach flasks (500 mL) each containing 80 g of rice. 
Distilled H2O (120 mL) was added to each flask, and the 
contents were soaked overnight before autoclaving at 15 psi 
for 30 min. After cooling to room temperature, each flask was 
inoculated with 5.0 mL of the spore inoculum and incubated at 
25 °C for 40 days. 
 
Extraction and Isolation. The fermented material was 
extracted with EtOAc (4 × 1.0 L), and the organic solvent was 
evaporated to dryness under vacuum to afford a crude extract 
(6.0 g). The extract was fractionated by silica gel VLC using 
petroleum ether–EtOAc gradient elution. The fraction (150 mg) 
eluted with 50% EtOAc was separated by Sephadex LH-20 
column chromatography (CC) eluting with 1:1 CH2Cl2–MeOH. 
The resulting subfractions were combined and further purified 
by semipreparative RP HPLC (Agilent Zorbax SB-C18 column; 
5 μm; 9.4 × 250 mm; 2 mL/min) to afford cytosporinols A (1; 
6.4 mg; tR 19.93 min; 45% CH3CN in H2O for 25 min) and B 
(2; 2.0 mg, tR 17.00 min; 25% CH3CN in H2O for 20 min). The 
fraction (300 mg) eluted with 30% EtOAc was eluted again 
through Sephadex LH-20 CC (1:1 CH2Cl2–MeOH) to afford 
cytosporinol C (3; 60.0 mg). 
 
Cytosporinol A (1): colorless oil; [α]25D   +86 (c 0.1, MeOH); 
UV (MeOH) λmax (log ε) 208 (3.36) nm; IR (neat) νmax 3424 
(br), 2933, 2866, 1709, 1446, 1230, 1094, 1064, 1054, 1011, 
975, 949 cm–1; 1H, 13C NMR, and HMBC data see Table 1; 
positive ion ESIMS m/z 303 [M + Na]+; HRESIMS m/z 
303.1564 (calcd for C16H24O4 Na, 303.1567). 
 
Preparation of (R)-(1a) and (S)-MTPA (1b) Esters.19 A 
sample of 1 (2.0 mg, 0.007 mmol), (S)-MTPA Cl (3.0 μL, 
0.017 mmol), and pyridine-d5 (0.5 mL) were allowed to react 
in an NMR tube at ambient temperature for 24 h, with the 1H 
NMR data of the R-MTPA ester derivative (1a) were obtained 
directly on the reaction mixture: 1H NMR (pyridine-d5, 400 
MHz) δ 5.54 (1H, d, J = 4.0 Hz, H-12), 5.51 (1H, d, J = 8.0 Hz, 
H-11), 4.32 (1H, s, H-10), 4.17 (1H, dd, J = 12, 4.0 Hz, H-6), 
3.70 (1H, t, J = 12 Hz, H-7a), 3.23 (3H, s, Me-16), 2.90 (1H, 
td, J = 8.0, 2.5 Hz, H-2), 2.62 (1H, ddd, J = 8.0, 4.0, 2.5 Hz, 
H-1), 2.16 (1H, dd, J = 12, 4.0 Hz, H-7b), 1.91 (1H, dd, J = 12, 
8.0 Hz, H-3a), 1.74 (3H, s, Me-15), 1.57 (3H, s, Me-13), 1.54 
(1H, dd, J = 12, 8.0 Hz, H-3b), 1.32 (3H, s, Me-14). 
 
Figure 5.  CD spectrum of 3 in DMSO containing Mo2(OAc)4 
 
Scheme 1.  Hypothetical biosynthetic pathways for compounds 
1–3 
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Similarly, the reaction mixture from another sample of 1 
(2.0 mg, 0.007 mmol), (R)-MTPA Cl (3.0 μL, 0.017 mmol), 
and pyridine-d5 (0.5 mL) was processed as described above for 
1a to afford 1b: 1H NMR (pyridine-d5, 400 MHz) δ 5.56 (1H, 
d, J = 4.0 Hz, H-12), 5.55 (1H, d, J = 8.0 Hz, H-11), 4.26 (1H, 
dd, J = 12, 4.0 Hz, H-6), 4.19 (1H, s, H-10), 3.70 (1H, t, J = 
12 Hz, H-7a), 3.23 (3H, s, ME-16), 2.92 (1H, td, J = 8.0, 2.5 
Hz, H-2), 2.91 (1H, ddd, J = 8.0, 4.0, 2.5 Hz, H-1), 2.15 (1H, 
dd, J = 12, 4.0 Hz, H-7b), 2.00 (1H, m, H-3a), 2.00 (1H, m, H-
3b), 1.65 (3H, s, Me-15), 1.61 (3H, s, Me-13), 1.35 (3H, s, 
Me-14). 
 
Cytosporinol B (2): colorless oil; [α]25D   –2.8 (c 0.1, MeOH); 
UV (MeOH) λmax (log ε) 208 (3.38) nm; IR (neat) νmax 3423 
(br), 2936, 1718, 1445, 1382, 1236, 1104, 1043, 968 cm–1; 1H, 
13C NMR, and HMBC data see Table 2; positive ion ESIMS 
m/z 303 [M + Na]+; HRESIMS m/z 303.1565 (calcd for 
C16H24O4 Na, 303.1567). 
 
Cytosporinol C (3): colorless needles (MeOH–H2O), mp 
149–152 °C; [α]25D   –8.8 (c 0.1, MeOH); UV (MeOH) λmax (log 
ε) 209 (3.38) nm; IR (neat) νmax 3473, 3444, 2960, 2930, 2874, 
1731, 1466, 1401, 1385, 1235, 1150, 1133, 1118, 1093, 1067, 
1038, 1000, 901 cm–1; 1H, 13C NMR, HMBC, and NOESY 
data see Table 2; positive ion ESIMS m/z 377 [M + Na]+; 
HRESIMS m/z 377.2300 (calcd for C20H34O5 Na, 377.2298). 
 
X-ray Crystallographic Analysis of 3.25 Upon crystal-
lization from MeOH–H2O (10:1) using the vapor diffusion 
method, colorless crystals were obtained for 3. A crystal (0.40 
× 0.30 × 0.08 mm) was separated from the sample and 
mounted on a glass fiber, and data were collected using a 
Rigaku Saturn CCD area detector with graphite-
monochromated Mo Kα radiation, λ = 0.71073 Ǻ at 173(2) K. 
Crystal data: C20H34O5, M = 354.47, space group orthorhombic, 
P212121; unit cell dimensions a = 5.8938 (17) Å, b = 13.939 (4) 
Å, c = 23.127 (7) Å, V = 1900.0 (10) Å3, Z = 4, Dcalcd = 1.239 
mg/m3, μ = 0.087 mm-1, F(000) = 776. The structure was 
solved by direct methods using SHELXL-9726 and refined 
using full-matrix least-squares difference Fourier techniques. 
All non-hydrogen atoms were refined with anisotropic 
displacement parameters, and all hydrogen atoms were placed 
in idealized positions and refined as riding atoms with the 
relative isotropic parameters. Absorption corrections were 
applied with the Siemens Area Detector Absorption Program 
(SADABS).27 The 12519 measurements yielded 2026 
independent reflections after equivalent data were averaged, 
and Lorentz and polarization corrections were applied. The 
final refinement gave R1 = 0.0493 and wR2 = 0.0990 [I > 2σ(I)]. 
 
Absolute Configuration of the 6,8-Diol Moiety in 3.20 
HPLC grade DMSO was dried with 4 Å molecular sieves. 
According to a published procedure, a mixture of 1:2 
diol/Mo2(OAc)4 for 3 was subjected to CD measurements at a 
concentration of 0.6 mg/mL. The first CD spectrum was 
recorded immediately after mixing, and its time evolution was 
monitored until stationary (about 10 min after mixing). The 
inherent CD was subtracted. The observed sign of the 
diagnostic band at around 400 nm in the induced CD spectrum 
was correlated to the absolute configuration of the 6,8-diol 
moiety. 
 
MTS Assay.28 The assay was run in triplicate. In a 96-well 
plate, each well was plated with 2–5 × 103 cells (depending on 
the cell multiplication rate). After cell attachment overnight, 
the medium was removed, and each well was treated with 50 
µL medium containing 0.1% DMSO, or appropriate 
concentrations of the test compounds and the positive control 
cisplatin (100 mM as stock solution of a compound in DMSO 
and serial dilutions; the test compounds showed good 
solubility in DMSO and did not precipitate when added to the 
cells). The plate was incubated for 72 h at 37 °C in a 
humidified, 5% CO2 atmosphere. Proliferation assessed by 
adding 20 μL of MTS (Promega) to each well in the dark, 
followed by a 90 min incubation at 37 °C. The assay plate was 
read at 490 nm using a microplate reader. 
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